The International Society for the Study and Exchange of evidence from Clinical research And Medical experience is a non for profit, multidisciplinary, scientific association, with following objectives:
With an increasing workload in daily practice and decreasing time available, it becomes harder for healthcare professionals to attend time-consuming congresses and meetings, to keep up-to-date with all new scientific data, to filter the information and apply the evidence in clinical practice in order to improve patient outcomes.
Due to the continuously increasing and fast evolving knowledge base, Continuous Medical Education (CME) is becoming more and more important, while related evaluation and accreditation is getting more regulated and stringent. ISSECAM wants to develop unique CME, addressing unmet needs of healthcare professionals at both a disease-specific and patient-specific level. The CME programmes, both online and offline, should offer high return [credits, learning satisfaction] on time investment.
ISSECAM wants to address the future needs of CME and clinical research in serious diseases.
ISSECAM is organised into committees to carry out their mission. The first three committees active are:
Search, download and share slides covering abstracts with the highest importance for clinical practice, presented at main urological/urogynaecological congresses enriched by clinical impact rating.
The Global Congress on Lower Urinary Tract Dysfunction brings together top experts and delegates for in-depth discussions on lower urinary tract disorders, with a strong focus on clinical decision making.
The Global Congress on Bladder Cancer brings together top experts and delegates from several disciplines, for an in-depth discussion of the different aspects of bladder cancer, with a focus on difficulties and dilemmas of clinical decision making.
The Global Congress on Prostate Cancer brings together top experts and delegates for in-depth discussions on prostate cancer, with a strong focus on clinical decision making.
The EMPaCT group, a multidisciplinary and international network of high volume, high quality centers, has a database of > 5800 high-risk PCa patients treated with radical prostatectomy and are actively involved in retrospective and prospective research to answer open questions in the field of PCa.
Search, download and share slides covering abstracts with the highest importance for clinical practice, presented at main GU congresses enriched by clinical impact rating.